Board Votes to Adopt Changes to Reagan-Udall Foundation By-Laws
On May 23, 2013, the Reagan Udall Foundation Board, by a vote of 8 to 0, amended the Foundation’s Bylaws to add three new available seats to the Board. These seats may be filled by persons falling into any of the categories described in the Reagan Udall statute and Bylaws except for representatives of FDA-regulated industry. Thus, the additional seats may be filled by representatives of (1) academic research organizations, (2) patient or consumer advocacy organizations, or (3) health care providers, or by (4) at large members with expertise or experience relevant to the purpose of the Foundation. The amendments to the Bylaws included additional changes meant to conform to other provisions of the Bylaws – such as the staggered term provisions – to this change.
The Board deemed this amendment appropriate to expand the scope of the Board’s experience and expertise, and to thus further its commitment, in keeping with the Foundation’s broad statutory mandate, to “advance the mission of the Food and Drug Administration to modernize medical, veterinary, food, food ingredient, and cosmetic product development, accelerate innovation, and enhance product safety.
Complete Reagan-Udall Foundation Bylaws can be found here.